iBio, Inc. is a biotechnology company that develops and commercializes plant-based biopharmaceuticals. The company's proprietary technology platform, iBioLaunch, uses plant cells to produce proteins for use in vaccines and therapeutic proteins. iBio, Inc. also provides contract development and manufacturing services to clients in the biopharmaceutical industry. The company was founded in 2008 and is headquartered in The Woodlands, Texas.